| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Research Unit (S-W.J., N.L.E.) Thoracic Diseases Research Unit (K.W.) Department of Internal Medicine (S-W.J., K.W., N.L.E.) Department of Biochemistry & Molecular Biology (N.L.E.) Mayo Clinic Rochester, Minnesota 55905
Human chorionic somatomammotropin (hCS) gene expression in the placenta is controlled by an enhancer (CSEn) containing SV40-related GT-IIC and SphI/SphII enhansons. These enhancers are controlled by members of the transcription enhancer factor-1 (TEF-1) family. Recently TEF-5, whose mRNA is abundant in placenta, was shown to bind cooperatively to a unique, tandemly repeated element in CSEn2, suggesting that TEF-5 regulates CSEn activity. However, expression of TEF-5 using a cDNA lacking the 5'-untranslated region and containing a modified translation initiation site was not accompanied by CSEn activation. Using nested, degenerate PCR primers corresponding to conserved TEF domains, several novel TEF-1-related cDNAs have been cloned from a human placental cDNA library. The open reading frame of one 3033-bp clone was identical to TEF-5 and contained 300- and 1423-bp 5'- and 3'-untranslated regions, respectively. The in vitrogenerated approximately 53-kDa TEF-5 polypeptide binds specifically to GT-IIC and SphI/SphII oligonucleotides. Overexpression of TEF-5 in BeWo cells using the intact 3033-bp cDNA transactivates the hCS and SV40 enhancers and artificial enhancers comprised of tandemly repeated GT-IIC enhansons, but not OCT enhansons. The data demonstrate that TEF-5 is a transactivator that is likely involved in the transactivation of CSEn enhancer function. Further, the data suggest that elements within the untranslated regions, initiation site, or both control TEF-5 expression in ways that influence its transactivation function.
This article has been cited by other articles:
 |
|
 |
|
  X. Liu, D. Zhao, L. Qin, J. Li, and H. Zeng Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells J. Biol. Chem., December 5, 2008; 283(49): 34159 - 34167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshida MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Kimura, D. Sizova, S. Handwerger, N. E. Cooke, and S. A. Liebhaber Epigenetic Activation of the Human Growth Hormone Gene Cluster during Placental Cytotrophoblast Differentiation Mol. Cell. Biol., September 15, 2007; 27(18): 6555 - 6568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Anbanandam, D. C. Albarado, C. T. Nguyen, G. Halder, X. Gao, and S. Veeraraghavan Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain PNAS, November 14, 2006; 103(46): 17225 - 17230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Azakie, L. LaMont, J. R. Fineman, and Y. He Divergent transcriptional enhancer factor-1 regulates the cardiac troponin T promoter Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1522 - C1534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Peng, Y. Huang, F. Jin, S.-W. Jiang, and A. H. Payne Transcription Enhancer Factor-5 and a GATA-Like Protein Determine Placental-Specific Expression of the Type I Human 3{beta}-Hydroxysteroid Dehydrogenase Gene, HSD3B1 Mol. Endocrinol., August 1, 2004; 18(8): 2049 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jin, L. D. Norquay, X. Yang, S. Gregoire, and P. A. Cattini Binding of AP-2 and ETS-Domain Family Members Is Associated with Enhancer Activity in the Hypersensitive Site III Region of the Human Growth Hormone/Chorionic Somatomammotropin Locus Mol. Endocrinol., March 1, 2004; 18(3): 574 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Maeda, J. R. Mazzulli, I. K. G. Farrance, and A. F. R. Stewart Mouse DTEF-1 (ETFR-1, TEF-5) Is a Transcriptional Activator in alpha 1-Adrenergic Agonist-stimulated Cardiac Myocytes J. Biol. Chem., June 28, 2002; 277(27): 24346 - 24352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vassilev, K. J. Kaneko, H. Shu, Y. Zhao, and M. L. DePamphilis TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm Genes & Dev., May 15, 2001; 15(10): 1229 - 1241. [Abstract] [Full Text]
|
|
|
|
|
|
J. Wu, A. Duggan, and M. Chalfie Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans Genes & Dev., March 15, 2001; 15(6): 789 - 802. [Abstract] [Full Text]
|
|
|
|
|
|
B. Belandia and M. G. Parker Functional Interaction between the p160 Coactivator Proteins and the Transcriptional Enhancer Factor Family of Transcription Factors J. Biol. Chem., September 29, 2000; 275(40): 30801 - 30805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Jiang, M. Dong, M. A. Trujillo, L. J. Miller, and N. L. Eberhardt DNA Binding of TEA/ATTS Domain Factors Is Regulated by Protein Kinase C Phosphorylation in Human Choriocarcinoma Cells J. Biol. Chem., June 22, 2001; 276(26): 23464 - 23470. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
